Literature DB >> 29762657

Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model.

Nicolas A Menzies1,2, Ted Cohen3, Andrew N Hill4, Reza Yaesoubi5, Kara Galer1, Emory Wolf1, Suzanne M Marks4, Joshua A Salomon1,6.   

Abstract

We estimated long-term tuberculosis (TB) trends in the US population and assessed prospects for TB elimination. We used a detailed simulation model allowing for changes in TB transmission, immigration, and other TB risk determinants. Five hypothetical scenarios were evaluated from 2017 to 2100: 1) maintain current TB prevention and treatment activities (base case); 2) provision of latent TB infection testing and treatment for new legal immigrants; 3) increased uptake of latent TB infection screening and treatment among high-risk populations, including a 3-month isoniazid-rifapentine regimen; 4) improved TB case detection; and 5) improved TB treatment quality. Under the base case, we estimate that by 2050, TB incidence will decline to 14 cases per million, a 52% (95% posterior interval (PI): 35, 67) reduction from 2016, and 82% (95% posterior interval: 78, 86) of incident TB will be among persons born outside of the United States. Intensified TB control could reduce incidence by 77% (95% posterior interval: 66, 85) by 2050. We predict TB may be eliminated in US-born but not non-US-born persons by 2100. Results were sensitive to numbers of people entering the United States with latent or active TB, and were robust to alternative interpretations of epidemiologic evidence. TB elimination in the United States remains a distant goal; however, strengthening TB prevention and treatment could produce important health benefits.

Entities:  

Mesh:

Year:  2018        PMID: 29762657      PMCID: PMC6119121          DOI: 10.1093/aje/kwy094

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  18 in total

1.  A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States.

Authors:  Anne Marie France; Juliana Grant; J Steve Kammerer; Thomas R Navin
Journal:  Am J Epidemiol       Date:  2015-10-13       Impact factor: 4.897

2.  Leveling of Tuberculosis Incidence - United States, 2013-2015.

Authors:  Jorge L Salinas; Godwin Mindra; Maryam B Haddad; Robert Pratt; Sandy F Price; Adam J Langer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-03-25       Impact factor: 17.586

3.  Disease extinction and community size: modeling the persistence of measles.

Authors:  M J Keeling; B T Grenfell
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

Review 4.  Tuberculosis prevention and control activities in the United States: an overview of the organization of tuberculosis services.

Authors:  N J Binkin; A A Vernon; P M Simone; E McCray; B I Miller; C W Schieffelbein; K G Castro
Journal:  Int J Tuberc Lung Dis       Date:  1999-08       Impact factor: 2.373

5.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

Authors:  James P Boyle; Theodore J Thompson; Edward W Gregg; Lawrence E Barker; David F Williamson
Journal:  Popul Health Metr       Date:  2010-10-22

6.  Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades.

Authors:  K G Castro; S M Marks; M P Chen; A N Hill; J E Becerra; R Miramontes; C A Winston; T R Navin; R H Pratt; K H Young; P A LoBue
Journal:  Int J Tuberc Lung Dis       Date:  2016-07       Impact factor: 2.373

7.  Using genotyping and geospatial scanning to estimate recent mycobacterium tuberculosis transmission, United States.

Authors:  Patrick K Moonan; Smita Ghosh; John E Oeltmann; J Steven Kammerer; Lauren S Cowan; Thomas R Navin
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

8.  Recent Transmission of Tuberculosis - United States, 2011-2014.

Authors:  Courtney M Yuen; J Steve Kammerer; Kala Marks; Thomas R Navin; Anne Marie France
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

Review 9.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

10.  Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Roque Miramontes; Andrew N Hill; Rachel S Yelk Woodruff; Lauren A Lambert; Thomas R Navin; Kenneth G Castro; Philip A LoBue
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

View more
  36 in total

1.  RE: "PROSPECTS FOR TUBERCULOSIS ELIMINATION IN THE UNITED STATES: RESULTS OF A TRANSMISSION DYNAMIC MODEL".

Authors: 
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

2.  Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.

Authors:  Suzanne M Marks; David W Dowdy; Nicolas A Menzies; Priya B Shete; Joshua A Salomon; Andrea Parriott; Sourya Shrestha; Jennifer Flood; Andrew N Hill
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

3.  Modeling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California.

Authors:  Andrea Parriott; James G Kahn; Haleh Ashki; Adam Readhead; Pennan M Barry; Alex J Goodell; Jennifer Flood; Priya B Shete
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

4.  Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017-2018).

Authors:  Garrett R Beeler Asay; Chee Kin Lam; Brock Stewart; Joan M Mangan; Laura Romo; Suzanne M Marks; Sapna Bamrah Morris; Caroline L Gummo; Chris E Keh; Andrew N Hill; Anila Thomas; Michelle Macaraig; Kristen St John; Teresita J Ampie; Christine Chuck; Joseph Burzynski
Journal:  Am J Public Health       Date:  2020-09-17       Impact factor: 9.308

Review 5.  Epidemiology of Tuberculosis in the United States.

Authors:  Adam J Langer; Thomas R Navin; Carla A Winston; Philip LoBue
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

6.  Estimates of Testing for Latent Tuberculosis Infection and Cost, United States, 2013.

Authors:  Suzanne M Marks; Rachel Yelk Woodruff; Kwame Owusu-Edusei; Garrett R Beeler Asay; Andrew N Hill
Journal:  Public Health Rep       Date:  2019-07-24       Impact factor: 2.792

7.  Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis.

Authors:  Sourya Shrestha; Sarah Cherng; Andrew N Hill; Sue Reynolds; Jennifer Flood; Pennan M Barry; Adam Readhead; Margaret Oxtoby; Michael Lauzardo; Tom Privett; Suzanne M Marks; David W Dowdy
Journal:  Am J Epidemiol       Date:  2019-09-01       Impact factor: 4.897

Review 8.  The impact of migration on tuberculosis in the United States.

Authors:  N A Menzies; A N Hill; T Cohen; J A Salomon
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

9.  Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States.

Authors:  Sourya Shrestha; Andrea Parriott; Nicolas A Menzies; Priya B Shete; Andrew N Hill; Suzanne M Marks; David W Dowdy
Journal:  Ann Am Thorac Soc       Date:  2020-12

10.  Contemporary Social Disparities in TB Infection and Disease in the USA: a Review.

Authors:  Grace A Noppert; Ryan E Malosh; Elizabeth B Moran; Shama D Ahuja; Jon Zelner
Journal:  Curr Epidemiol Rep       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.